Two Sigma Securities, LLC Co Diagnostics, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.7 $17,773 - $29,916	17,598 New	17,598 $21,000
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.5 $447 - $670	-447 Reduced 2.69%	16,179 $21,000
Q3 2023 Nov 14, 2023	BUY	$1.03 - $1.85 $17,124 - $30,758	16,626 New	16,626 $17,000
Q3 2022 Nov 14, 2022	BUY	$2.87 - $7.01 $44,054 - $107,603	15,350 New	15,350 $49,000
Q1 2018 May 15, 2018	SELL	$1.56 - $3.2 $15,882 - $32,579	-10,181 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.38 - $6.72 $24,230 - $68,416	10,181	10,181 $28,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $28M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.